Literature DB >> 10750059

Detecting dose response with contrasts.

W H Stewart1, S J Ruberg.   

Abstract

Analyses of dose response studies should separate the question of the existence of a dose response relationship from questions of functional form and finding the optimal dose. A well-chosen contrast among the estimated effects of the studied doses can make a powerful test for detecting the existence of a dose response relationship. A contrast-based test attains its greatest power when the pattern of the coefficients has the same shape as the true dose response relationship. However, it loses power when the contrast shape and the true dose response shape are not similar. Thus, a primary test based on a single contrast is often risky. Two (or more) appropriately chosen contrasts can assure sufficient power to justify the cost of a multiplicity adjustment. An example shows the success of a two-contrast procedure in detecting dose response, which had frustrated several standard procedures. Copyright 2000 John Wiley & Sons, Ltd.

Mesh:

Substances:

Year:  2000        PMID: 10750059     DOI: 10.1002/(sici)1097-0258(20000415)19:7<913::aid-sim397>3.0.co;2-2

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  6 in total

1.  A novel immuno-competitive capture mass spectrometry strategy for protein-protein interaction profiling reveals that LATS kinases regulate HCV replication through NS5A phosphorylation.

Authors:  Hélène Meistermann; Junjun Gao; Sabrina Golling; Jens Lamerz; Sophie Le Pogam; Manuel Tzouros; Sailaja Sankabathula; Lore Gruenbaum; Isabel Nájera; Hanno Langen; Klaus Klumpp; Angélique Augustin
Journal:  Mol Cell Proteomics       Date:  2014-07-20       Impact factor: 5.911

2.  Trend tests for the evaluation of exposure-response relationships in epidemiological exposure studies.

Authors:  Ludwig A Hothorn; Michael Vaeth; Torsten Hothorn
Journal:  Epidemiol Perspect Innov       Date:  2009-03-06

Review 3.  Recommendations for designing and analysing multi-arm non-inferiority trials: a review of methodology and current practice.

Authors:  Jake Emmerson; Susan Todd; Julia M Brown
Journal:  Trials       Date:  2021-06-26       Impact factor: 2.279

4.  Dose-Response of Aerobic Exercise on Cognition: A Community-Based, Pilot Randomized Controlled Trial.

Authors:  Eric D Vidoni; David K Johnson; Jill K Morris; Angela Van Sciver; Colby S Greer; Sandra A Billinger; Joseph E Donnelly; Jeffrey M Burns
Journal:  PLoS One       Date:  2015-07-09       Impact factor: 3.240

5.  Binding to SMN2 pre-mRNA-protein complex elicits specificity for small molecule splicing modifiers.

Authors:  Manaswini Sivaramakrishnan; Kathleen D McCarthy; Sébastien Campagne; Sylwia Huber; Sonja Meier; Angélique Augustin; Tobias Heckel; Hélène Meistermann; Melanie N Hug; Pascale Birrer; Ahmed Moursy; Sarah Khawaja; Roland Schmucki; Nikos Berntenis; Nicolas Giroud; Sabrina Golling; Manuel Tzouros; Balazs Banfai; Gonzalo Duran-Pacheco; Jens Lamerz; Ying Hsiu Liu; Thomas Luebbers; Hasane Ratni; Martin Ebeling; Antoine Cléry; Sergey Paushkin; Adrian R Krainer; Frédéric H-T Allain; Friedrich Metzger
Journal:  Nat Commun       Date:  2017-11-14       Impact factor: 14.919

6.  AJM300, a novel oral antagonist of α4-integrin, sustains an increase in circulating lymphocytes: A randomised controlled trial in healthy male subjects.

Authors:  Hiroyuki Fukase; Toshifumi Kajioka; Ichiro Oikawa; Naoki Ikeda; Hidetoshi Furuie
Journal:  Br J Clin Pharmacol       Date:  2020-01-28       Impact factor: 4.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.